FDA Eyes Regulatory Oversight Of Bolus Calculator Apps
This article was originally published in The Gray Sheet
Executive Summary
During a recent panel discussion on bolus insulin calculator apps, experts called on FDA to establish some oversight, but said precise steps should vary depending on whether the app is intended to incorporate new data sources.